Case Report
BibTex RIS Cite

A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy

Year 2022, Volume: 2 Issue: 1, 9 - 11, 30.04.2022
https://doi.org/10.52818/cjmr.v2i1.53

Abstract

The increasing prevalence of illicit drugs abuse is a significant social and medical problem. This situation can cause various results, ranging from simple intoxication to fatal organ failure. The most common illicit is ecstasy (MDMA) and marijuana (cannabis). In this case report we tried to present a hepatic encephalopathy case due to using these drugs.

Sentetik Kannabinoid ve Ekstazinin Kötüye Kullanıldığı Bir Hepatik Ensefalopati Olgusu

Year 2022, Volume: 2 Issue: 1, 9 - 11, 30.04.2022
https://doi.org/10.52818/cjmr.v2i1.53

Abstract

Önemli bir sosyal ve tıbbi sorun olan, yasadışı uyuşturucu maddelerin istismarın prevalansı artmaktadır. Bu durum basit zehirlenmeden ölümcül organ yetmezliğine kadar çeşitli sonuçlara neden olabilir. En yaygın yasadışı maddeler ekstazi (MDMA) ve esrardır (cannabis). Bu olgu sunumunda bu maddeleri kullanmaktan kaynaklanan hepatik ensefalopati olgusunu sunmaya çalıştık.

There are 0 citations in total.

Details

Primary Language English
Subjects Clinical Sciences
Journal Section Case Report
Authors

Gamze Gokalp This is me 0000-0002-0369-6379

Tugce Nalbant This is me 0000-0002-7408-2382

Yuksel Bıcılıoglu This is me 0000-0003-4531-3978

Emel Berksoy This is me 0000-0002-6831-1353

Sefika Bardak This is me 0000-0003-1211-6943

Gulsah Demır This is me 0000-0001-7841-4682

Alper Cıcek This is me 0000-0001-9684-2736

Submission Date January 8, 2022
Publication Date April 30, 2022
Published in Issue Year 2022 Volume: 2 Issue: 1

Cite

APA Gokalp, G., Nalbant, T., Bıcılıoglu, Y., Berksoy, E., Bardak, S., Demır, G., & Cıcek, A. (2022). A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy. Güncel Tıbbi Araştırmaları Dergisi, 2(1), 9-11. https://doi.org/10.52818/cjmr.v2i1.53
AMA 1.Gokalp G, Nalbant T, Bıcılıoglu Y, et al. A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy. CJMR. 2022;2(1):9-11. doi:10.52818/cjmr.v2i1.53
Chicago Gokalp, Gamze, Tugce Nalbant, Yuksel Bıcılıoglu, et al. 2022. “A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy”. Güncel Tıbbi Araştırmaları Dergisi 2 (1): 9-11. https://doi.org/10.52818/cjmr.v2i1.53.
EndNote Gokalp G, Nalbant T, Bıcılıoglu Y, Berksoy E, Bardak S, Demır G, Cıcek A (April 1, 2022) A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy. Güncel Tıbbi Araştırmaları Dergisi 2 1 9–11.
IEEE [1]G. Gokalp et al., “A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy”, CJMR, vol. 2, no. 1, pp. 9–11, Apr. 2022, doi: 10.52818/cjmr.v2i1.53.
ISNAD Gokalp, Gamze - Nalbant, Tugce - Bıcılıoglu, Yuksel - Berksoy, Emel - Bardak, Sefika - Demır, Gulsah - Cıcek, Alper. “A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy”. Güncel Tıbbi Araştırmaları Dergisi 2/1 (April 1, 2022): 9-11. https://doi.org/10.52818/cjmr.v2i1.53.
JAMA 1.Gokalp G, Nalbant T, Bıcılıoglu Y, Berksoy E, Bardak S, Demır G, Cıcek A. A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy. CJMR. 2022;2:9–11.
MLA Gokalp, Gamze, et al. “A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy”. Güncel Tıbbi Araştırmaları Dergisi, vol. 2, no. 1, Apr. 2022, pp. 9-11, doi:10.52818/cjmr.v2i1.53.
Vancouver 1.Gokalp G, Nalbant T, Bıcılıoglu Y, Berksoy E, Bardak S, Demır G, et al. A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy. CJMR [Internet]. 2022 Apr. 1;2(1):9-11. Available from: https://izlik.org/JA97ZC27GT